Vizimpro 30 MG Oral Tablet

RxCUI: 2058926
RxNorm name: Vizimpro 30 MG Oral Tablet
Display name: Vizimpro 30 MG Oral Tablet
Full name: Vizimpro 30 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vizimpro	DACOMITINIB	Pfizer Laboratories Div Pfizer Inc	4ab27d2f-e385-4e9c-b324-fa69c10b855a	2026-06-23	Warnings, Adverse reactions	Exact identifier rxcui: 2058926

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
4ab27d2f-e385-4e9c-b324-fa69c10b855a	Vizimpro 30 MG Oral Tablet [PSN] · dacomitinib 30 MG Oral Tablet [Vizimpro] [SBD] · Vizimpro 30 MG Oral Tablet [SY]	3	8	These highlights do not include all the information needed to use VIZIMPRO safely and effectively. See full prescribing information for VIZIMPRO. VIZIMPRO ® (dacomitinib) tablets, for oral use Initial U.S. Approval: 2018	20251218